Literature DB >> 13809099

Megaloblastic anaemia due to phenobarbitone; the convulsant action of therapeutic doses of folic acid.

I CHANARIN, J LAIDLAW, L W LOUGHRIDGE, D L MOLLIN.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPERCHROMIC/etiology; FOLIC ACID/therapy; PHENOBARBITAL/toxicology

Mesh:

Substances:

Year:  1960        PMID: 13809099      PMCID: PMC1966921          DOI: 10.1136/bmj.1.5179.1099

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  The application in general medical conditions of a visual method of assessing and representing generalized electroencephalographic abnormalities.

Authors:  J LAIDLAW
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-02       Impact factor: 10.154

2.  The clearance from the plasma of folic acid injected intravenously in normal subjects and patients with megaloblastic anaemia.

Authors:  I CHANARIN; D L MOLLIN; B B ANDERSON
Journal:  Br J Haematol       Date:  1958-10       Impact factor: 6.998

3.  The absorption of folic acid.

Authors:  I CHANARIN; B B ANDERSON; D L MOLLIN
Journal:  Br J Haematol       Date:  1958-04       Impact factor: 6.998

4.  Megaloblastic anemia from methophenobarbital.

Authors:  R J CALVERT; E HURWORTH; A L MACBEAN
Journal:  Blood       Date:  1958-09       Impact factor: 22.113

5.  Urinary excretion of formiminoglutamic acid by human subjects after antifolic acid therapy.

Authors:  H H HIATT; M GOLDSTEIN; H TABOR
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

6.  Megaloblastic anaemia due to barbiturates.

Authors:  Q J HOBSON; D L MOLLIN; J G SELWYN
Journal:  Lancet       Date:  1956-11-24       Impact factor: 79.321

7.  Observations on megaloblastic anaemias after primidone.

Authors:  H FULD; E H MOORHOUSE
Journal:  Br Med J       Date:  1956-05-05

8.  Megaloblastic anaemia due to phenytoin sodium.

Authors:  C F HAWKINS; M J MEYNELL
Journal:  Lancet       Date:  1954-10-09       Impact factor: 79.321

9.  The nature of the glutamic acid excreted in folic acid deficiency.

Authors:  M SILVERMAN; R C GARDINER; H A BAKERMAN
Journal:  J Biol Chem       Date:  1952-02       Impact factor: 5.157

10.  Vitamin B12 assay in body fluids using Euglena gracilis.

Authors:  G I M ROSS
Journal:  J Clin Pathol       Date:  1952-08       Impact factor: 3.411

View more
  22 in total

1.  ANTICONVULSANTS.

Authors:  A PHILLIPS
Journal:  Br Med J       Date:  1963-10-12

2.  FOLIC-ACID DEFICIENCY IN RHEUMATOID ARTHRITIS.

Authors:  K R GOUGH; C MCCARTHY; A E READ; D L MOLLIN; A H WATERS
Journal:  Br Med J       Date:  1964-01-25

3.  Incidence of macrocytic anaemia in rheumatoid arthritis.

Authors:  R E PARTRIDGE; J J DUTHIE
Journal:  Br Med J       Date:  1963-01-12

4.  Megaloblastic anaemia during combined phensuximide and phenobarbitone therapy.

Authors:  A DOIG; J B STANTON
Journal:  Br Med J       Date:  1961-10-14

5.  Urinary excretion of histidine derivatives in megaloblastic anaemia and other conditions and comparison with the folic acid clearance test.

Authors:  I CHANARIN; M C BENNETT; V BERRY
Journal:  J Clin Pathol       Date:  1962-05       Impact factor: 3.411

6.  The effects of chronic drug administration on hepatic enzyme induction and folate metabolism.

Authors:  D Labadarios; J W Dickerson; D V Parke; E G Lucas; G H Obuwa
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

7.  Folate interactions with cerebral G proteins.

Authors:  D M Hartley; S R Snodgrass
Journal:  Neurochem Res       Date:  1990-07       Impact factor: 3.996

8.  Anemia in general practice. Laboratory services.

Authors:  I A Cook
Journal:  J Coll Gen Pract       Date:  1967-03

9.  Folic acid deficiency and epilepsy.

Authors:  J W Norris; R F Pratt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  Lymphadenopathy and megaloblastic anaemia in patient receiving primidone.

Authors:  A O Langlands; N Maclean; J G Pearson; E R Williamson
Journal:  Br Med J       Date:  1967-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.